Watch Ticker

GRI Bio, Inc. Common Stock

Go to GRI Bio, Inc. Common Stock Website

$1.27

-0.01 (-0.41%)
Live
Previous Close

$1.28

Day Range

$1.25 - $1.34

Previous Day Range

$1.27 - $1.35

Market Cap

$3.3 million USD

Day Vol.

96772

Previous Day Vol.

123613

Currency

USD

Primary Exchange

Nasdaq

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

GRI Bio participated in a virtual investor segment discussing its Phase 2a study interim biomarker data for Idiopathic Pulmonary Fibrosis, highlighting potential therapeutic advances in treating inflammatory and fibrotic diseases using NKT cell modulators.

Related tickers: GRI.

Read Full Article

Windtree Therapeutics, a biotechnology company, announced the appointment of Leanne Kelly to its board of directors. Ms. Kelly has significant public company executive experience and will serve as an independent director and chair of the audit committee.

Related tickers: WINT, GRI, OPTN.

Read Full Article
Trending Tickers

Please sign in to view